Sequencing data for "Replication timing alterations are associated with mutation acquisition during tumour evolution in breast and lung cancer"
Repli-seq data for "Replication timing alterations are associated with mutation acquisition during tumour evolution in breast and lung cancer"
- 10 samples
- DAC: EGAC00001000632
- Technology: Illumina HiSeq 4000
TRACERx Non-small cell lung cancer
”The Francis Crick Institute allows access to published datasets upon written application and signature of a Data Access Agreement (DAA) to be provided. Applications require approval by the TRACERx Data Access Committee (DAC), who assess whether the proposed work is allowed given patient consent, as well as the scientific purpose. Requestors will be provided with a data access form upon contact with the TRACERx DAC.”
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |